Angiodynamic Inc [ANGO] stock prices are down -0.57% to $8.69 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The ANGO shares have lost -6.76% over the last week, with a monthly amount drifted -14.47%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Angiodynamic Inc [NASDAQ: ANGO] stock has seen the most recent analyst activity on July 16, 2025, when Lake Street initiated its Buy rating and assigned the stock a price target of $24. Previously, Oppenheimer upgraded its rating to Outperform on April 05, 2024, and kept the price target unchanged to $12. On September 25, 2023, H.C. Wainwright initiated with a Buy rating and assigned a price target of $19 on the stock. Raymond James downgraded its rating to a Outperform and decreased its price target to $13 on April 17, 2023. Canaccord Genuity upgraded its rating to a Buy and raised its price target to $37 on October 15, 2021. In a note dated November 25, 2020, Raymond James upgraded an Strong Buy rating on this stock but restated the target price of $18.
The stock price of Angiodynamic Inc [ANGO] has been fluctuating between $5.83 and $13.50 over the past year. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. Angiodynamic Inc [NASDAQ: ANGO] shares were valued at $8.69 at the most recent close of the market. An investor can expect a potential return of 95.63% based on the average ANGO price forecast.
Analyzing the ANGO fundamentals
The Angiodynamic Inc [NASDAQ:ANGO] reported sales of 292.50M for trailing twelve months, representing a surge of 12.93%. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -0.08%, Pretax Profit Margin comes in at -0.12%, and Net Profit Margin reading is -0.12%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.18 and Total Capital is -0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.46 points at the first support level, and at 8.24 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.91, and for the 2nd resistance point, it is at 9.14.
Ratios To Look Out For
It’s worth pointing out that Angiodynamic Inc [NASDAQ:ANGO]’s Current Ratio is 2.21. On the other hand, the Quick Ratio is 1.40, and the Cash Ratio is 0.73. Considering the valuation of this stock, the price to sales ratio is 1.21, the price to book ratio is 1.95.
Transactions by insiders
Recent insider trading involved Nighan Warren JR, SVP Quality and Regulatory, that happened on Jan 16 ’25 when 4060.0 shares were sold. Officer, Nighan Warren JR completed a deal on Jan 16 ’25 to buy 4060.0 shares. Meanwhile, SVP Quality and Regulatory Nighan Warren JR bought 768.0 shares on Oct 07 ’24.
